Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Steve Scalia
Advertisement
Steve Scalia is president of Tanner Pharm Group
Articles by Steve Scalia
Advertisement
Latest Updated Articles
Partnering to Respond to a Possible Nuclear ThreatPublished: May 25th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Moderna Investing $140 Million in Massachusetts Manufacturing Facility
2
Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers
3
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer
4
How the FDA Commissioner’s National Priority Vouchers Reshape Manufacturing, Pricing & Global Strategy
5
